Corticosteroids for NMOSD

Corticosteroids are a class of powerful immune-suppressing medications that are used as a first-line option for managing relapses in people with neuromyelitis optica spectrum disorder (NMOSD).

Sometimes called glucocorticoids or steroids, corticosteroids for NMOSD may also play a role in longer-term disease management for some people, although the potential benefits of these medications must be weighed against their risk of side effects.

What are corticosteroids?

Corticosteroids are prescription medications that reduce inflammation in the body. They are lab-made compounds that mimic cortisol, a naturally occurring hormone. Cortisol helps regulate the body’s response to stress, and it reduces inflammation and immune activity.

NMOSD is an autoimmune disease in which the immune system mistakenly launches inflammatory attacks against the nervous system, causing a range of possible symptoms. For most people, these attacks are driven by self-reactive antibodies. Relapses are periods of increased inflammatory activity that, if not treated promptly, can cause irreversible nervous system damage.

By suppressing the immune system, corticosteroids can help control these inflammatory attacks, and in some cases, prevent them.

How corticosteroids are used in NMOSD

In NMOSD, corticosteroids are most often used as a short-term treatment to get an active relapse under control. They may also sometimes be used when transitioning between other therapies or as a long-term way of preventing relapses.

The most common steroids for NMOSD include:

  • prednisone/prednisolone: typically taken orally
  • methylprednisolone: typically given as an into-the-vein (intravenous/IV) infusion

NMOSD relapse treatment

The standard of care for an NMOSD relapse is a short course of high-dose IV methylprednisolone (sold as Solu-Medrol and others) lasting three to five days. This can help quickly suppress inflammation and reduce the risk of lasting damage from the relapse, especially if started as soon as possible after the relapse begins.

After IV steroid treatment for NMOSD relapses, it is common to receive an oral corticosteroid taper. This involves taking the medication by mouth for a few more weeks, with the dose gradually decreased before it is stopped completely and other long-term therapies are started.

Tapering the dose in this way helps reduce the risk of side effects while avoiding a sudden increase in immune activity that could result from stopping corticosteroids abruptly. It also allows the body’s own cortisol production to recover. Patients should not stop or change their steroid dose without their prescriber’s guidance, as this can lead to unsafe side effects.

Bridging therapy

Some long-term treatments for NMOSD take time to reach their full effect. During this transition, doctors may prescribe low-dose oral corticosteroids to help prevent relapses. Once the new treatment is fully established, the corticosteroid dose can be tapered to reduce the risk of long-term side effects. The duration of bridging therapy varies, but often lasts around three to six months.

Long-term corticosteroid treatment

In general, corticosteroids are not preferred as a long-term treatment for NMOSD, either alone or when added to other therapies. There is no clear evidence that they are more effective than other options, and long-term use can cause serious side effects.

However, doctors may recommend long-term corticosteroid use for relapse prevention in certain circumstances, including if:

  • a person is not eligible to receive or cannot tolerate other targeted therapies
  • other therapies have failed to control a person’s relapses
  • a person is in an area where other treatment options aren’t available

Scroll horizontally to view all columns -->

Regimen Steroid type Used for: 
Relapse control Intravenous, followed by oral taper First-line option for stopping a relapse
Bridging therapy Oral To prevent relapses when switching between other therapies
Relapse prevention Oral Long-term relapse prevention when other therapies cannot be used or are not available

Side effects

Corticosteroid side effects in NMOSD may be similar to those seen with the medication’s uses for other purposes. They may include:

  • increased appetite
  • weight gain
  • skin changes, such as bruising or acne
  • water retention, leading to swelling or puffiness
  • stomach irritation
  • muscle weakness
  • mood swings
  • increased body hair growth

The risk of serious side effects increases when these medications are used long-term. This can lead to:

  • weakened immune system and infections
  • high blood sugar or diabetes
  • high blood pressure
  • weak bones (osteoporosis)
  • Cushing’s syndrome, a condition caused by excessive cortisol activity

During corticosteroid use, healthcare providers will monitor patients for potential side effects.


Neuromyelitis News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

FAQs about corticosteroids for NMOSD